How beta-amyloid peptide affects brain cells
Author Information
Author(s): Aiste Jekabsone, Palwinder K Mander, Anna Tickler, Martyn Sharpe, Guy C Brown
Primary Institution: Department of Biochemistry, University of Cambridge
Hypothesis
Can fibrillar beta-amyloid peptide Aβ1–40 stimulate microglial proliferation and cytokine production via activation of NADPH oxidase?
Conclusion
Fibrillar Aβ1–40 induces microglial proliferation through NADPH oxidase and TNF-α release.
Supporting Evidence
- Fibrillar Aβ1–40 peptide induced microglial proliferation to 204% of initial cell number after 24 hours.
- Microglial proliferation was completely blocked by NADPH oxidase inhibitor apocynin.
- TNF-α levels increased significantly after treatment with fibrillar Aβ1–40.
Takeaway
This study shows that a protein related to Alzheimer's disease can make certain brain cells multiply and release substances that cause inflammation.
Methodology
Primary mixed glial cultures from 7-day-old Wistar rats were treated with Aβ1–40, and microglial proliferation and cytokine levels were measured.
Limitations
The study is based on in vitro cell cultures, which may not fully replicate in vivo conditions.
Participant Demographics
7-day-old Wistar rats were used for cell cultures.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website